Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1988 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.
Sterkens A, Lambert J, Bervoets A. Sterkens A, et al. Clin Exp Med. 2021 May;21(2):215-230. doi: 10.1007/s10238-020-00673-w. Epub 2021 Jan 1. Clin Exp Med. 2021. PMID: 33386567 Review.
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebrows, or even the entire body. ...The prognosis is uncertain and is negatively influenced by the subtypes alopecia totalis and alop …
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebr …
Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL, Luk DCK, Leung AKC, Ng C, Loo SKF. Hon KL, et al. Recent Pat Inflamm Allergy Drug Discov. 2020;14(2):117-132. doi: 10.2174/1872213X14999200728145822. Recent Pat Inflamm Allergy Drug Discov. 2020. PMID: 32723274 Review.
BACKGROUND: Alopecia Areata (AA) is a systemic autoimmune condition that usually starts in childhood. OBJECTIVE: This article aims to review genetics, therapy, prognosis, and recent patents for AA. METHODS: We used clinical queries and keywords "alopecia area …
BACKGROUND: Alopecia Areata (AA) is a systemic autoimmune condition that usually starts in childhood. OBJECTIVE: This article aims to …
Vitiligo as a reaction to topical treatment with diphencyprone.
Hatzis J, Gourgiotou K, Tosca A, Varelzidis A, Stratigos J. Hatzis J, et al. Dermatologica. 1988;177(3):146-8. doi: 10.1159/000248532. Dermatologica. 1988. PMID: 3169339
During the topical treatment of 45 patients, who had extensive forms of alopecia areata, with the allergen diphencyprone, 3 of them (6.7%) developed vitiligo. Two were females and 1 male aged 53, 19 and 28 years respectively. None of these patients had a personal or fam …
During the topical treatment of 45 patients, who had extensive forms of alopecia areata, with the allergen diphencyprone, 3 of them ( …
PUVA treatment for alopecia areata.
Lassus A, Kianto U, Johansson E, Juvakoski T. Lassus A, et al. Dermatologica. 1980;161(5):298-304. doi: 10.1159/000250381. Dermatologica. 1980. PMID: 7439478
41 patients with severe alopecia areata were treated with either local or oral 8-methoxypsoralen and UVA irradiations. ...The number of irradiations required for regrowth varied but 20--40 treatments were sufficient in most cases with a positive response. Patients w …
41 patients with severe alopecia areata were treated with either local or oral 8-methoxypsoralen and UVA irradiations. ...The …
Treatment of alopecia areata with three different PUVA modalities.
Lassus A, Eskelinen A, Johansson E. Lassus A, et al. Photodermatol. 1984 Jun;1(3):141-4. Photodermatol. 1984. PMID: 6527956
Seventy-six patients with severe alopecia areata were treated with either local or oral 8-methoxypsoralen and UVA irradiations. ...Non-atopic patients responded better than patients with atopy, while a family history of alopecia areata did not seem to …
Seventy-six patients with severe alopecia areata were treated with either local or oral 8-methoxypsoralen and UVA irradiations …